Two-Dimensional Intravascular Near-Infrared Fluorescence Molecular Imaging of Inflammation in Atherosclerosis and Stent-Induced Vascular Injury

被引:129
作者
Jaffer, Farouc A. [1 ,2 ,3 ]
Calfon, Marcella A. [1 ,2 ]
Rosenthal, Amir [1 ,2 ,6 ,7 ]
Mallas, Georgios [1 ,2 ,8 ]
Razansky, R. Nika [6 ,7 ]
Mauskapf, Adam [1 ,2 ]
Weissleder, Ralph [3 ,4 ]
Libby, Peter [5 ]
Ntziachristos, Vasilis [6 ,7 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02114 USA
[6] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Munich, Germany
[7] Tech Univ Munich, Munich, Germany
[8] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
atherosclerosis; inflammation; intravascular imaging; molecular imaging; stent; DRUG-ELUTING STENT; IN-VIVO; CARDIOVASCULAR-DISEASE; CYSTEINE PROTEASES; THROMBOSIS; DESIGN; SYSTEM;
D O I
10.1016/j.jacc.2011.02.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study sought to develop a 2-dimensional (2D) intravascular near-infrared fluorescence (NIRF) imaging strategy for investigation of arterial inflammation in coronary-sized vessels. Background Molecular imaging of arterial inflammation could provide new insights into the pathogenesis of acute myocardial infarction stemming from coronary atheromata and implanted stents. Presently, few high-resolution approaches can image inflammation in coronary-sized arteries in vivo. Methods A new 2.9-F rotational, automated pullback 2D imaging catheter was engineered and optimized for 360 degrees viewing intravascular NIRF imaging. In conjunction with the cysteine protease-activatable imaging reporter Prosense VM110 (VisEn Medical, Woburn, Massachusetts), intra-arterial 2D NIRF imaging was performed in rabbit aortas with atherosclerosis (n = 10) or implanted coronary bare-metal stents (n = 10, 3.5-mm diameter, day 7 post-implantation). Intravascular ultrasound provided coregistered anatomical images of arteries. After sacrifice, specimens underwent ex vivo NIRF imaging, fluorescence microscopy, and histological and immunohistochemical analyses. Results Imaging of coronary artery-scaled phantoms demonstrated 8-sector angular resolution and submillimeter axial resolution, nanomolar sensitivity to NIR fluorochromes, and modest NIRF light attenuation through blood. High-resolution NIRF images of vessel wall inflammation with signal-to-noise ratios > 10 were obtained in real-time through blood, without flushing or occlusion. In atherosclerosis, 2D NIRF, intravascular ultrasound-NIRF fusion, microscopy, and immunoblotting studies provided insight into the spatial distribution of plaque protease activity. In stent-implanted vessels, real-time imaging illuminated an edge-based pattern of stent-induced arterial inflammation. Conclusions A new 2D intravascular NIRF imaging strategy provides high-resolution in vivo spatial mapping of arterial inflammation in coronary-sized arteries and reveals increased inflammation-regulated cysteine protease activity in atheromata and stent-induced arterial injury. (J Am Coll Cardiol 2011;57:2516-26) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:2516 / 2526
页数:11
相关论文
共 20 条
[1]   Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques [J].
Calfon, Marcella A. ;
Vinegoni, Claudio ;
Ntziachristos, Vasilis ;
Jaffer, Farouc A. .
JOURNAL OF BIOMEDICAL OPTICS, 2010, 15 (01)
[2]   In vivo imaging of proteolytic activity in atherosclerosis [J].
Chen, JQ ;
Tung, CH ;
Mahmood, U ;
Ntziachristos, V ;
Gyurko, R ;
Fishman, MC ;
Huang, PL ;
Weissleder, R .
CIRCULATION, 2002, 105 (23) :2766-2771
[3]  
HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529
[4]   Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis [J].
Jaffer, Farouc A. ;
Vinegoni, Claudio ;
John, Michael C. ;
Aikawa, Elena ;
Gold, Herman K. ;
Finn, Aloke V. ;
Ntziachristos, Vasilis ;
Libby, Peter ;
Weissleder, Ralph .
CIRCULATION, 2008, 118 (18) :1802-1809
[5]   Molecular Imaging of cardiovascular disease [J].
Jaffer, Farouc A. ;
Libby, Peter ;
Weissleder, Ralph .
CIRCULATION, 2007, 116 (09) :1052-1061
[6]   Emerging Molecular Targets for Intravascular Imaging of High-Risk Plaques [J].
Kim J.W. ;
Jaffer F.A. .
Current Cardiovascular Imaging Reports, 2010, 3 (4) :237-247
[7]   Lysosomal cysteine proteases in atherosclerosis [J].
Liu, JA ;
Sukhova, GK ;
Sun, JS ;
Xu, WH ;
Libby, P ;
Shi, GP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1359-1366
[8]   Drug-eluting stent and coronary thrombosis -: Biological mechanisms and clinical implications [J].
Luescher, Thomas F. ;
Steffel, Jan ;
Eberli, Franz R. ;
Joner, Michael ;
Nakazawa, Gaku ;
Tanner, Felix C. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (08) :1051-1058
[9]   Cathepsin cysteine proteases in cardiovascular disease [J].
Lutgens, Suzanne P. M. ;
Cleutjens, Kitty B. J. M. ;
Daemen, Mat J. A. P. ;
Heeneman, Sylvia .
FASEB JOURNAL, 2007, 21 (12) :3029-3041
[10]  
Moore JE, 2009, J ENDOVASC THER, V16, P1